ClinicalTrials.Veeva

Menu

BIOCLEAN FIRST CARE EX in Combination With Biofinity Lens

CooperVision logo

CooperVision

Status

Completed

Conditions

Myopia

Treatments

Other: Aosept Clearcare / comfilcon A
Other: Bioclean First Care EX / comfilcon A

Study type

Interventional

Funder types

Industry

Identifiers

NCT02196766
CVJ-EX-MKTG-1818

Details and patient eligibility

About

To determine if patients are unreactive to the lens care solution / Biofinity combination.

Full description

To determine if patients are unreactive to the lens care solution / Biofinity combination in this cross-over study.

Enrollment

30 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Is over 18 years of age (inclusive)
  • Has had a self-reported visual exam in the last two years
  • Is currently an adapted spherical soft CL wearer
  • Has a CL spherical prescription between - 0.25 and - 12.00 (inclusive)
  • Has less than 1.00D spectacle cylinder in each eye.
  • Is correctable to a visual acuity of 20/20 or better in both eyes
  • Has clear corneas and no active ocular disease
  • Has read, understood and signed the information consent letter.
  • Is willing to comply with the wear schedule (at least 40 hrs per week)
  • Is willing to comply with the visit schedule

Exclusion criteria

  • Has never worn contact lenses before.
  • Currently wears rigid gas permeable contact lenses.
  • Has a history of not achieving comfortable CL wear (5 days per week; > 8 hours/day)
  • Has a CL prescription outside the range of - 0.25 to -12.00D
  • Has a spectacle cylinder greater than -0.75D of cylinder in either eye.
  • Has best corrected spectacle distance vision worse than 20/20 in either eye.
  • Has any systemic disease affecting ocular health.
  • Is using any systemic or topical medications that will affect ocular health.
  • Has any ocular pathology or severe insufficiency of lacrimal secretion
  • Has persistent, clinically significant corneal or conjunctival staining
  • Has active neovascularization or any central corneal scars.
  • Is aphakic.
  • Is pregnant or lactating.
  • Has undergone corneal refractive surgery.
  • Is participating in any other type of eye related clinical or research study.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

30 participants in 2 patient groups

Bioclean First Care EX combo, then Aosept Clearcare combo
Active Comparator group
Description:
Subjects dispensed Bioclean First Care EX / comfilcon A combination then crossed over to the Aosept Clearcare / comfilcon A combination.
Treatment:
Other: Aosept Clearcare / comfilcon A
Other: Bioclean First Care EX / comfilcon A
Aosept Clearcare combo, then Bioclean First Care EX combo
Active Comparator group
Description:
Subjects dispensed Aosept Clearcare / comfilcon A combination then crossed over to the Bioclean First Care EX / comfilcon A combination.
Treatment:
Other: Aosept Clearcare / comfilcon A
Other: Bioclean First Care EX / comfilcon A

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems